C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets

Diabetologia

Volumn 44, Issue 5, 2001, Pages 646-653

  Tatarkiewicz, K ^a   Garcia, M ^a   Omer, A ^a   Van Schilfgaarde, R ^b   Weir, G C ^a   De Vos, P ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

C peptide; Diabetic mice; Meal challenge; Microencapsulation; Pancreatic islet; Transplantation

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INSULIN RELEASE; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROVOCATION TEST; RAT; TEST MEAL; TRANSPLANTATION;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD GLUCOSE; C-PEPTIDE; CAPSULES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KINETICS; MALE; MICE; MICE, INBRED STRAINS; POLYLYSINE; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; THEOPHYLLINE; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035004697     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051672     Document Type: Article

References (36)

1. Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice
2. Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets
3. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation
4. Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients
5. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres
6. CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice
7. Synergistic effect of microencapsulation and immunoalteration on islet allograft survival in bioartificial pancreas
8. Glucose control and long-term survival in Bio Breeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression
9. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets
10. Transplantation of islets using microencapsulation: Studies in diabetic rodents and dogs
11. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression
12. Glucose tolerance and plasma insulin response to intravenous glucose infusion and test meal in rats with microencapsulated islet allografts
13. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets
14. Kinetics of intraperitoneally infused insulin in rat. Functional implications for the bioartificial pancreas
15. Insulin secretion in streptozotocin-diabetic rats transplanted with immunoisolated islets
16. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion fates in the dog
17. Measurement of glucose concentrations in rats: Differences between glucose meter and plasma laboratory results
18. An improved method for isolation of mouse pancreatic islets
19. Factors influencing the adequacy of microencapuslation of rat pancreatic islets
20. Association between capsule diameter, adequacy of encapsulation, and survival of microencapuslated rat islet allografts
21. Prolonged xenograft survival of islets infected with small doses of adenovirus containing CTLA4Ig
22. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets
23. Glucose-insulin kinetics of a bioartificial pancreas made of an AN69 hydrogel hollow fiber containing porcine islets and implanted in diabetic mice
24. Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses
25. Microencapsulation of neonatal porcine islets: Protection from human antibody/complement-mediated cytolysis in vitro and long-term reversal of diabetes in nude mice
26. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes
27. Immunoisolation of adult porcine islets for the treatment of diabetes mellitus
28. Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets
29. In vitro kinetics of insulin release by microencapsulated rat islets: Effect of the size of the microcapsules
30. An encapsulation system for the immunoisolation of pancreatic islets
31. Intermittent intraperitoneal implantation of islets in rat islet transplantation
32. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats
33. The efficacy of intraperitoneal pancreatic islet isografts in the reversal of diabetes in rats
34. Vulnerability of islets in the immediate posttransplantation period
35. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth
36. Use of a physiologic pharmacokinetic model of glucose homeostatis for assessment of performance requirements for improved insulin therapies